nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallium nitrate—RRM2—Gemcitabine—kidney cancer	0.562	1	CbGbCtD
Gallium nitrate—IL1B—nephron—kidney cancer	0.0183	0.165	CbGeAlD
Gallium nitrate—BGLAP—urine—kidney cancer	0.0171	0.155	CbGeAlD
Gallium nitrate—TF—urine—kidney cancer	0.0131	0.118	CbGeAlD
Gallium nitrate—ATP6V1B2—nephron tubule—kidney cancer	0.00539	0.0488	CbGeAlD
Gallium nitrate—ATP6V1B2—renal system—kidney cancer	0.0049	0.0444	CbGeAlD
Gallium nitrate—ATP6V1B2—kidney—kidney cancer	0.00474	0.0429	CbGeAlD
Gallium nitrate—ATP6V1B2—cortex of kidney—kidney cancer	0.00462	0.0418	CbGeAlD
Gallium nitrate—ATP6V1B2—gonad—kidney cancer	0.0044	0.0398	CbGeAlD
Gallium nitrate—ATP6V1B2—cardiac atrium—kidney cancer	0.00439	0.0398	CbGeAlD
Gallium nitrate—BGLAP—renal system—kidney cancer	0.00419	0.038	CbGeAlD
Gallium nitrate—BGLAP—kidney—kidney cancer	0.00405	0.0367	CbGeAlD
Gallium nitrate—IL1B—renal system—kidney cancer	0.00359	0.0325	CbGeAlD
Gallium nitrate—IL1B—kidney—kidney cancer	0.00347	0.0314	CbGeAlD
Gallium nitrate—Hypophosphataemia—Temsirolimus—kidney cancer	0.00338	0.0225	CcSEcCtD
Gallium nitrate—Edema of lower extremities—Capecitabine—kidney cancer	0.00335	0.0223	CcSEcCtD
Gallium nitrate—TF—renal system—kidney cancer	0.0032	0.029	CbGeAlD
Gallium nitrate—Hypophosphataemia—Pazopanib—kidney cancer	0.00318	0.0212	CcSEcCtD
Gallium nitrate—RRM2—renal system—kidney cancer	0.00316	0.0286	CbGeAlD
Gallium nitrate—Lung infiltration—Everolimus—kidney cancer	0.00312	0.0207	CcSEcCtD
Gallium nitrate—TF—kidney—kidney cancer	0.00309	0.028	CbGeAlD
Gallium nitrate—RRM2—kidney—kidney cancer	0.00305	0.0277	CbGeAlD
Gallium nitrate—Lung infiltration—Erlotinib—kidney cancer	0.00301	0.02	CcSEcCtD
Gallium nitrate—Encephalopathy—Pazopanib—kidney cancer	0.00288	0.0192	CcSEcCtD
Gallium nitrate—TF—gonad—kidney cancer	0.00287	0.026	CbGeAlD
Gallium nitrate—RRM2—gonad—kidney cancer	0.00283	0.0257	CbGeAlD
Gallium nitrate—Pleural effusion—Temsirolimus—kidney cancer	0.00257	0.017	CcSEcCtD
Gallium nitrate—Hypophosphataemia—Everolimus—kidney cancer	0.00251	0.0167	CcSEcCtD
Gallium nitrate—Blindness—Sunitinib—kidney cancer	0.0022	0.0146	CcSEcCtD
Gallium nitrate—Hypophosphataemia—Sorafenib—kidney cancer	0.00218	0.0145	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Pazopanib—kidney cancer	0.00217	0.0144	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Temsirolimus—kidney cancer	0.00215	0.0143	CcSEcCtD
Gallium nitrate—Hypophosphataemia—Sunitinib—kidney cancer	0.0021	0.014	CcSEcCtD
Gallium nitrate—Lung infiltration—Gemcitabine—kidney cancer	0.00209	0.0139	CcSEcCtD
Gallium nitrate—RRM2—Gefitinib—Erlotinib—kidney cancer	0.00203	0.383	CbGdCrCtD
Gallium nitrate—Pleural effusion—Everolimus—kidney cancer	0.00191	0.0127	CcSEcCtD
Gallium nitrate—Blindness—Vincristine—kidney cancer	0.00186	0.0124	CcSEcCtD
Gallium nitrate—Pleural effusion—Sorafenib—kidney cancer	0.00166	0.011	CcSEcCtD
Gallium nitrate—Rales—Capecitabine—kidney cancer	0.00164	0.0109	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Everolimus—kidney cancer	0.0016	0.0106	CcSEcCtD
Gallium nitrate—Pleural effusion—Sunitinib—kidney cancer	0.00159	0.0106	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Sorafenib—kidney cancer	0.00149	0.00987	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Sunitinib—kidney cancer	0.00143	0.0095	CcSEcCtD
Gallium nitrate—Hypophosphataemia—Paclitaxel—kidney cancer	0.00141	0.00937	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Sorafenib—kidney cancer	0.00139	0.00921	CcSEcCtD
Gallium nitrate—Lethargy—Pazopanib—kidney cancer	0.00137	0.00911	CcSEcCtD
Gallium nitrate—RRM2—Vinorelbine—Vinblastine—kidney cancer	0.00136	0.257	CbGdCrCtD
Gallium nitrate—RRM2—Vinorelbine—Vincristine—kidney cancer	0.00136	0.257	CbGdCrCtD
Gallium nitrate—Hypocalcaemia—Sunitinib—kidney cancer	0.00133	0.00886	CcSEcCtD
Gallium nitrate—Pleural effusion—Gemcitabine—kidney cancer	0.00128	0.0085	CcSEcCtD
Gallium nitrate—Encephalopathy—Paclitaxel—kidney cancer	0.00128	0.00849	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Dactinomycin—kidney cancer	0.00126	0.00839	CcSEcCtD
Gallium nitrate—Renal failure acute—Everolimus—kidney cancer	0.00115	0.00763	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Gemcitabine—kidney cancer	0.00115	0.00762	CcSEcCtD
Gallium nitrate—Renal failure acute—Erlotinib—kidney cancer	0.00111	0.00737	CcSEcCtD
Gallium nitrate—Lethargy—Everolimus—kidney cancer	0.00108	0.00719	CcSEcCtD
Gallium nitrate—Pleural effusion—Paclitaxel—kidney cancer	0.00107	0.00711	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Gemcitabine—kidney cancer	0.00107	0.00711	CcSEcCtD
Gallium nitrate—Encephalopathy—Capecitabine—kidney cancer	0.00105	0.00696	CcSEcCtD
Gallium nitrate—Hearing impaired—Gemcitabine—kidney cancer	0.00103	0.00684	CcSEcCtD
Gallium nitrate—Renal failure acute—Sorafenib—kidney cancer	0.000997	0.00663	CcSEcCtD
Gallium nitrate—Oedema peripheral—Temsirolimus—kidney cancer	0.000972	0.00646	CcSEcCtD
Gallium nitrate—Renal failure acute—Sunitinib—kidney cancer	0.00096	0.00638	CcSEcCtD
Gallium nitrate—Coma—Vincristine—kidney cancer	0.000943	0.00627	CcSEcCtD
Gallium nitrate—Oedema peripheral—Pazopanib—kidney cancer	0.000916	0.00608	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Paclitaxel—kidney cancer	0.000896	0.00595	CcSEcCtD
Gallium nitrate—Pleural effusion—Capecitabine—kidney cancer	0.000879	0.00584	CcSEcCtD
Gallium nitrate—Hearing impaired—Paclitaxel—kidney cancer	0.000861	0.00572	CcSEcCtD
Gallium nitrate—Erythema—Temsirolimus—kidney cancer	0.000859	0.00571	CcSEcCtD
Gallium nitrate—Lethargy—Dactinomycin—kidney cancer	0.000856	0.00569	CcSEcCtD
Gallium nitrate—Erythema—Pazopanib—kidney cancer	0.000809	0.00538	CcSEcCtD
Gallium nitrate—Anaemia—Temsirolimus—kidney cancer	0.000794	0.00527	CcSEcCtD
Gallium nitrate—Blindness—Doxorubicin—kidney cancer	0.000783	0.00521	CcSEcCtD
Gallium nitrate—Hypothermia—Doxorubicin—kidney cancer	0.000774	0.00514	CcSEcCtD
Gallium nitrate—Body temperature decreased—Doxorubicin—kidney cancer	0.000774	0.00514	CcSEcCtD
Gallium nitrate—Leukopenia—Temsirolimus—kidney cancer	0.000769	0.00511	CcSEcCtD
Gallium nitrate—Anaemia—Pazopanib—kidney cancer	0.000748	0.00497	CcSEcCtD
Gallium nitrate—Hypophosphataemia—Doxorubicin—kidney cancer	0.000746	0.00496	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Capecitabine—kidney cancer	0.000735	0.00488	CcSEcCtD
Gallium nitrate—Hallucination—Everolimus—kidney cancer	0.00073	0.00485	CcSEcCtD
Gallium nitrate—Leukopenia—Pazopanib—kidney cancer	0.000724	0.00481	CcSEcCtD
Gallium nitrate—Oedema peripheral—Everolimus—kidney cancer	0.000723	0.0048	CcSEcCtD
Gallium nitrate—Hearing impaired—Capecitabine—kidney cancer	0.000707	0.0047	CcSEcCtD
Gallium nitrate—Optic neuritis—Doxorubicin—kidney cancer	0.000705	0.00469	CcSEcCtD
Gallium nitrate—Renal failure acute—Paclitaxel—kidney cancer	0.000645	0.00428	CcSEcCtD
Gallium nitrate—Erythema—Everolimus—kidney cancer	0.000639	0.00424	CcSEcCtD
Gallium nitrate—Dyspnoea—Temsirolimus—kidney cancer	0.000625	0.00415	CcSEcCtD
Gallium nitrate—Erythema—Erlotinib—kidney cancer	0.000616	0.0041	CcSEcCtD
Gallium nitrate—Lethargy—Paclitaxel—kidney cancer	0.000607	0.00404	CcSEcCtD
Gallium nitrate—Oedema peripheral—Sunitinib—kidney cancer	0.000604	0.00401	CcSEcCtD
Gallium nitrate—Constipation—Temsirolimus—kidney cancer	0.000599	0.00398	CcSEcCtD
Gallium nitrate—Tinnitus—Sorafenib—kidney cancer	0.000594	0.00395	CcSEcCtD
Gallium nitrate—Paraesthesia—Pazopanib—kidney cancer	0.000593	0.00394	CcSEcCtD
Gallium nitrate—Anaemia—Vinblastine—kidney cancer	0.000593	0.00394	CcSEcCtD
Gallium nitrate—Anaemia—Everolimus—kidney cancer	0.00059	0.00392	CcSEcCtD
Gallium nitrate—Dyspnoea—Pazopanib—kidney cancer	0.000589	0.00391	CcSEcCtD
Gallium nitrate—Leukopenia—Vinblastine—kidney cancer	0.000574	0.00381	CcSEcCtD
Gallium nitrate—Leukopenia—Everolimus—kidney cancer	0.000572	0.0038	CcSEcCtD
Gallium nitrate—Pleural effusion—Doxorubicin—kidney cancer	0.000566	0.00376	CcSEcCtD
Gallium nitrate—Erythema—Sorafenib—kidney cancer	0.000555	0.00368	CcSEcCtD
Gallium nitrate—Body temperature increased—Temsirolimus—kidney cancer	0.000554	0.00368	CcSEcCtD
Gallium nitrate—RRM2—Azacitidine—Gemcitabine—kidney cancer	0.000549	0.103	CbGdCrCtD
Gallium nitrate—Erythema—Sunitinib—kidney cancer	0.000534	0.00355	CcSEcCtD
Gallium nitrate—Renal failure acute—Capecitabine—kidney cancer	0.000529	0.00352	CcSEcCtD
Gallium nitrate—Hypersensitivity—Temsirolimus—kidney cancer	0.000516	0.00343	CcSEcCtD
Gallium nitrate—Hallucination—Vincristine—kidney cancer	0.000516	0.00343	CcSEcCtD
Gallium nitrate—Anaemia—Sorafenib—kidney cancer	0.000513	0.00341	CcSEcCtD
Gallium nitrate—Tachycardia—Everolimus—kidney cancer	0.000509	0.00338	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Doxorubicin—kidney cancer	0.000508	0.00337	CcSEcCtD
Gallium nitrate—Erythema—Dactinomycin—kidney cancer	0.000505	0.00336	CcSEcCtD
Gallium nitrate—Lethargy—Capecitabine—kidney cancer	0.000498	0.00331	CcSEcCtD
Gallium nitrate—Leukopenia—Sorafenib—kidney cancer	0.000496	0.0033	CcSEcCtD
Gallium nitrate—Pruritus—Temsirolimus—kidney cancer	0.000496	0.00329	CcSEcCtD
Gallium nitrate—Anaemia—Sunitinib—kidney cancer	0.000493	0.00328	CcSEcCtD
Gallium nitrate—Oedema peripheral—Gemcitabine—kidney cancer	0.000485	0.00322	CcSEcCtD
Gallium nitrate—Diarrhoea—Temsirolimus—kidney cancer	0.00048	0.00319	CcSEcCtD
Gallium nitrate—Leukopenia—Sunitinib—kidney cancer	0.000478	0.00317	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Doxorubicin—kidney cancer	0.000474	0.00315	CcSEcCtD
Gallium nitrate—Paraesthesia—Vinblastine—kidney cancer	0.00047	0.00312	CcSEcCtD
Gallium nitrate—Paraesthesia—Everolimus—kidney cancer	0.000468	0.00311	CcSEcCtD
Gallium nitrate—Pruritus—Pazopanib—kidney cancer	0.000467	0.0031	CcSEcCtD
Gallium nitrate—Anaemia—Dactinomycin—kidney cancer	0.000467	0.0031	CcSEcCtD
Gallium nitrate—Dyspnoea—Everolimus—kidney cancer	0.000465	0.00309	CcSEcCtD
Gallium nitrate—Leukopenia—Dactinomycin—kidney cancer	0.000452	0.003	CcSEcCtD
Gallium nitrate—Diarrhoea—Pazopanib—kidney cancer	0.000452	0.003	CcSEcCtD
Gallium nitrate—Dyspnoea—Erlotinib—kidney cancer	0.000448	0.00298	CcSEcCtD
Gallium nitrate—Constipation—Vinblastine—kidney cancer	0.000448	0.00297	CcSEcCtD
Gallium nitrate—Constipation—Everolimus—kidney cancer	0.000446	0.00296	CcSEcCtD
Gallium nitrate—Vomiting—Temsirolimus—kidney cancer	0.000446	0.00296	CcSEcCtD
Gallium nitrate—Rash—Temsirolimus—kidney cancer	0.000442	0.00294	CcSEcCtD
Gallium nitrate—Dermatitis—Temsirolimus—kidney cancer	0.000442	0.00293	CcSEcCtD
Gallium nitrate—Feeling abnormal—Vinblastine—kidney cancer	0.000431	0.00287	CcSEcCtD
Gallium nitrate—Constipation—Erlotinib—kidney cancer	0.00043	0.00286	CcSEcCtD
Gallium nitrate—Feeling abnormal—Everolimus—kidney cancer	0.00043	0.00285	CcSEcCtD
Gallium nitrate—Erythema—Gemcitabine—kidney cancer	0.000428	0.00284	CcSEcCtD
Gallium nitrate—Vomiting—Pazopanib—kidney cancer	0.00042	0.00279	CcSEcCtD
Gallium nitrate—Anaemia—Vincristine—kidney cancer	0.000417	0.00277	CcSEcCtD
Gallium nitrate—Rash—Pazopanib—kidney cancer	0.000416	0.00277	CcSEcCtD
Gallium nitrate—Nausea—Temsirolimus—kidney cancer	0.000416	0.00277	CcSEcCtD
Gallium nitrate—Dermatitis—Pazopanib—kidney cancer	0.000416	0.00276	CcSEcCtD
Gallium nitrate—Body temperature increased—Everolimus—kidney cancer	0.000412	0.00274	CcSEcCtD
Gallium nitrate—Oedema peripheral—Paclitaxel—kidney cancer	0.000406	0.0027	CcSEcCtD
Gallium nitrate—Leukopenia—Vincristine—kidney cancer	0.000404	0.00268	CcSEcCtD
Gallium nitrate—Dyspnoea—Sorafenib—kidney cancer	0.000403	0.00268	CcSEcCtD
Gallium nitrate—Body temperature increased—Erlotinib—kidney cancer	0.000398	0.00264	CcSEcCtD
Gallium nitrate—Coma—Doxorubicin—kidney cancer	0.000396	0.00263	CcSEcCtD
Gallium nitrate—Anaemia—Gemcitabine—kidney cancer	0.000396	0.00263	CcSEcCtD
Gallium nitrate—Nausea—Pazopanib—kidney cancer	0.000392	0.00261	CcSEcCtD
Gallium nitrate—Paraesthesia—Sunitinib—kidney cancer	0.000391	0.0026	CcSEcCtD
Gallium nitrate—Dyspnoea—Sunitinib—kidney cancer	0.000388	0.00258	CcSEcCtD
Gallium nitrate—Constipation—Sorafenib—kidney cancer	0.000387	0.00257	CcSEcCtD
Gallium nitrate—Hypersensitivity—Vinblastine—kidney cancer	0.000386	0.00256	CcSEcCtD
Gallium nitrate—Hypersensitivity—Everolimus—kidney cancer	0.000384	0.00255	CcSEcCtD
Gallium nitrate—Tinnitus—Paclitaxel—kidney cancer	0.000384	0.00255	CcSEcCtD
Gallium nitrate—Leukopenia—Gemcitabine—kidney cancer	0.000383	0.00255	CcSEcCtD
Gallium nitrate—Constipation—Sunitinib—kidney cancer	0.000372	0.00247	CcSEcCtD
Gallium nitrate—Pruritus—Everolimus—kidney cancer	0.000369	0.00245	CcSEcCtD
Gallium nitrate—Erythema—Paclitaxel—kidney cancer	0.000358	0.00238	CcSEcCtD
Gallium nitrate—Diarrhoea—Vinblastine—kidney cancer	0.000358	0.00238	CcSEcCtD
Gallium nitrate—Body temperature increased—Sorafenib—kidney cancer	0.000358	0.00238	CcSEcCtD
Gallium nitrate—Diarrhoea—Everolimus—kidney cancer	0.000357	0.00237	CcSEcCtD
Gallium nitrate—Pruritus—Erlotinib—kidney cancer	0.000356	0.00236	CcSEcCtD
Gallium nitrate—Body temperature increased—Sunitinib—kidney cancer	0.000344	0.00229	CcSEcCtD
Gallium nitrate—Diarrhoea—Erlotinib—kidney cancer	0.000344	0.00229	CcSEcCtD
Gallium nitrate—Renal failure acute—Doxorubicin—kidney cancer	0.000341	0.00227	CcSEcCtD
Gallium nitrate—Feeling abnormal—Dactinomycin—kidney cancer	0.00034	0.00226	CcSEcCtD
Gallium nitrate—Hypersensitivity—Sorafenib—kidney cancer	0.000333	0.00222	CcSEcCtD
Gallium nitrate—Oedema peripheral—Capecitabine—kidney cancer	0.000333	0.00221	CcSEcCtD
Gallium nitrate—Vomiting—Vinblastine—kidney cancer	0.000333	0.00221	CcSEcCtD
Gallium nitrate—Vomiting—Everolimus—kidney cancer	0.000331	0.0022	CcSEcCtD
Gallium nitrate—Anaemia—Paclitaxel—kidney cancer	0.000331	0.0022	CcSEcCtD
Gallium nitrate—Paraesthesia—Vincristine—kidney cancer	0.000331	0.0022	CcSEcCtD
Gallium nitrate—Rash—Everolimus—kidney cancer	0.000329	0.00218	CcSEcCtD
Gallium nitrate—Dermatitis—Everolimus—kidney cancer	0.000328	0.00218	CcSEcCtD
Gallium nitrate—Body temperature increased—Dactinomycin—kidney cancer	0.000326	0.00217	CcSEcCtD
Gallium nitrate—Lethargy—Doxorubicin—kidney cancer	0.000321	0.00213	CcSEcCtD
Gallium nitrate—Leukopenia—Paclitaxel—kidney cancer	0.000321	0.00213	CcSEcCtD
Gallium nitrate—Hypersensitivity—Sunitinib—kidney cancer	0.000321	0.00213	CcSEcCtD
Gallium nitrate—Pruritus—Sorafenib—kidney cancer	0.00032	0.00213	CcSEcCtD
Gallium nitrate—Vomiting—Erlotinib—kidney cancer	0.00032	0.00213	CcSEcCtD
Gallium nitrate—Rash—Erlotinib—kidney cancer	0.000317	0.00211	CcSEcCtD
Gallium nitrate—Dermatitis—Erlotinib—kidney cancer	0.000317	0.00211	CcSEcCtD
Gallium nitrate—Tinnitus—Capecitabine—kidney cancer	0.000315	0.00209	CcSEcCtD
Gallium nitrate—Constipation—Vincristine—kidney cancer	0.000315	0.00209	CcSEcCtD
Gallium nitrate—Paraesthesia—Gemcitabine—kidney cancer	0.000314	0.00208	CcSEcCtD
Gallium nitrate—Dyspnoea—Gemcitabine—kidney cancer	0.000312	0.00207	CcSEcCtD
Gallium nitrate—Nausea—Vinblastine—kidney cancer	0.000311	0.00207	CcSEcCtD
Gallium nitrate—Nausea—Everolimus—kidney cancer	0.00031	0.00206	CcSEcCtD
Gallium nitrate—Diarrhoea—Sorafenib—kidney cancer	0.00031	0.00206	CcSEcCtD
Gallium nitrate—Pruritus—Sunitinib—kidney cancer	0.000308	0.00205	CcSEcCtD
Gallium nitrate—Hypersensitivity—Dactinomycin—kidney cancer	0.000304	0.00202	CcSEcCtD
Gallium nitrate—Constipation—Gemcitabine—kidney cancer	0.000299	0.00199	CcSEcCtD
Gallium nitrate—Nausea—Erlotinib—kidney cancer	0.000299	0.00199	CcSEcCtD
Gallium nitrate—Diarrhoea—Sunitinib—kidney cancer	0.000298	0.00198	CcSEcCtD
Gallium nitrate—Confusional state—Paclitaxel—kidney cancer	0.000295	0.00196	CcSEcCtD
Gallium nitrate—Erythema—Capecitabine—kidney cancer	0.000294	0.00195	CcSEcCtD
Gallium nitrate—Body temperature increased—Vincristine—kidney cancer	0.000291	0.00193	CcSEcCtD
Gallium nitrate—Feeling abnormal—Gemcitabine—kidney cancer	0.000288	0.00191	CcSEcCtD
Gallium nitrate—Vomiting—Sorafenib—kidney cancer	0.000288	0.00191	CcSEcCtD
Gallium nitrate—Tachycardia—Paclitaxel—kidney cancer	0.000286	0.0019	CcSEcCtD
Gallium nitrate—Rash—Sorafenib—kidney cancer	0.000285	0.0019	CcSEcCtD
Gallium nitrate—Dermatitis—Sorafenib—kidney cancer	0.000285	0.00189	CcSEcCtD
Gallium nitrate—Diarrhoea—Dactinomycin—kidney cancer	0.000282	0.00187	CcSEcCtD
Gallium nitrate—Vomiting—Sunitinib—kidney cancer	0.000277	0.00184	CcSEcCtD
Gallium nitrate—Body temperature increased—Gemcitabine—kidney cancer	0.000276	0.00184	CcSEcCtD
Gallium nitrate—Rash—Sunitinib—kidney cancer	0.000275	0.00182	CcSEcCtD
Gallium nitrate—Dermatitis—Sunitinib—kidney cancer	0.000274	0.00182	CcSEcCtD
Gallium nitrate—Anaemia—Capecitabine—kidney cancer	0.000272	0.00181	CcSEcCtD
Gallium nitrate—Hypersensitivity—Vincristine—kidney cancer	0.000271	0.0018	CcSEcCtD
Gallium nitrate—Nausea—Sorafenib—kidney cancer	0.000269	0.00179	CcSEcCtD
Gallium nitrate—Leukopenia—Capecitabine—kidney cancer	0.000263	0.00175	CcSEcCtD
Gallium nitrate—Paraesthesia—Paclitaxel—kidney cancer	0.000263	0.00175	CcSEcCtD
Gallium nitrate—Vomiting—Dactinomycin—kidney cancer	0.000262	0.00174	CcSEcCtD
Gallium nitrate—Dyspnoea—Paclitaxel—kidney cancer	0.000261	0.00173	CcSEcCtD
Gallium nitrate—Rash—Dactinomycin—kidney cancer	0.00026	0.00173	CcSEcCtD
Gallium nitrate—Nausea—Sunitinib—kidney cancer	0.000259	0.00172	CcSEcCtD
Gallium nitrate—Diarrhoea—Vincristine—kidney cancer	0.000252	0.00167	CcSEcCtD
Gallium nitrate—Constipation—Paclitaxel—kidney cancer	0.00025	0.00166	CcSEcCtD
Gallium nitrate—Pruritus—Gemcitabine—kidney cancer	0.000247	0.00164	CcSEcCtD
Gallium nitrate—Nausea—Dactinomycin—kidney cancer	0.000245	0.00163	CcSEcCtD
Gallium nitrate—Confusional state—Capecitabine—kidney cancer	0.000242	0.00161	CcSEcCtD
Gallium nitrate—Feeling abnormal—Paclitaxel—kidney cancer	0.000241	0.0016	CcSEcCtD
Gallium nitrate—Diarrhoea—Gemcitabine—kidney cancer	0.000239	0.00159	CcSEcCtD
Gallium nitrate—Tachycardia—Capecitabine—kidney cancer	0.000234	0.00156	CcSEcCtD
Gallium nitrate—Vomiting—Vincristine—kidney cancer	0.000234	0.00156	CcSEcCtD
Gallium nitrate—Rash—Vincristine—kidney cancer	0.000232	0.00154	CcSEcCtD
Gallium nitrate—Dermatitis—Vincristine—kidney cancer	0.000232	0.00154	CcSEcCtD
Gallium nitrate—Body temperature increased—Paclitaxel—kidney cancer	0.000231	0.00154	CcSEcCtD
Gallium nitrate—Vomiting—Gemcitabine—kidney cancer	0.000222	0.00148	CcSEcCtD
Gallium nitrate—Rash—Gemcitabine—kidney cancer	0.00022	0.00146	CcSEcCtD
Gallium nitrate—Dermatitis—Gemcitabine—kidney cancer	0.00022	0.00146	CcSEcCtD
Gallium nitrate—Nausea—Vincristine—kidney cancer	0.000219	0.00145	CcSEcCtD
Gallium nitrate—Paraesthesia—Capecitabine—kidney cancer	0.000216	0.00143	CcSEcCtD
Gallium nitrate—Hypersensitivity—Paclitaxel—kidney cancer	0.000216	0.00143	CcSEcCtD
Gallium nitrate—Oedema peripheral—Doxorubicin—kidney cancer	0.000215	0.00143	CcSEcCtD
Gallium nitrate—Dyspnoea—Capecitabine—kidney cancer	0.000214	0.00142	CcSEcCtD
Gallium nitrate—Nausea—Gemcitabine—kidney cancer	0.000208	0.00138	CcSEcCtD
Gallium nitrate—Pruritus—Paclitaxel—kidney cancer	0.000207	0.00138	CcSEcCtD
Gallium nitrate—Constipation—Capecitabine—kidney cancer	0.000205	0.00136	CcSEcCtD
Gallium nitrate—Tinnitus—Doxorubicin—kidney cancer	0.000203	0.00135	CcSEcCtD
Gallium nitrate—Diarrhoea—Paclitaxel—kidney cancer	0.0002	0.00133	CcSEcCtD
Gallium nitrate—IL1B—Signaling by Interleukins—RAF1—kidney cancer	0.0002	0.00117	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—SFRP2—kidney cancer	0.0002	0.00117	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—MTOR—kidney cancer	0.0002	0.00117	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—RELA—kidney cancer	0.000199	0.00116	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Capecitabine—kidney cancer	0.000198	0.00131	CcSEcCtD
Gallium nitrate—IL1B—Allograft Rejection—VEGFA—kidney cancer	0.000196	0.00114	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—ITPR2—kidney cancer	0.000196	0.00114	CbGpPWpGaD
Gallium nitrate—RRM2—E2F transcription factor network—MYC—kidney cancer	0.000195	0.00114	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—EGR1—kidney cancer	0.000194	0.00113	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CUL7—kidney cancer	0.000193	0.00113	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—MAPK3—kidney cancer	0.000193	0.00113	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Capecitabine—kidney cancer	0.00019	0.00126	CcSEcCtD
Gallium nitrate—Erythema—Doxorubicin—kidney cancer	0.00019	0.00126	CcSEcCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IFNA2—kidney cancer	0.000188	0.0011	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—CDKN1B—kidney cancer	0.000188	0.00109	CbGpPWpGaD
Gallium nitrate—Vomiting—Paclitaxel—kidney cancer	0.000186	0.00124	CcSEcCtD
Gallium nitrate—RRM2—G1/S Transition—CDKN1B—kidney cancer	0.000185	0.00108	CbGpPWpGaD
Gallium nitrate—IL1B—Alzheimers Disease—MAPK3—kidney cancer	0.000185	0.00108	CbGpPWpGaD
Gallium nitrate—Rash—Paclitaxel—kidney cancer	0.000184	0.00123	CcSEcCtD
Gallium nitrate—Dermatitis—Paclitaxel—kidney cancer	0.000184	0.00122	CcSEcCtD
Gallium nitrate—IL1B—Leptin signaling pathway—MAPK1—kidney cancer	0.000184	0.00107	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—JUN—kidney cancer	0.000183	0.00107	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—PTGS2—kidney cancer	0.00018	0.00105	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—IL2—kidney cancer	0.000179	0.00105	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—JUN—kidney cancer	0.000179	0.00104	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—SRMS—kidney cancer	0.000177	0.00103	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Capecitabine—kidney cancer	0.000177	0.00118	CcSEcCtD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—CDKN2A—kidney cancer	0.000176	0.00103	CbGpPWpGaD
Gallium nitrate—IL1B—Alzheimers Disease—MAPK1—kidney cancer	0.000176	0.00103	CbGpPWpGaD
Gallium nitrate—Anaemia—Doxorubicin—kidney cancer	0.000175	0.00116	CcSEcCtD
Gallium nitrate—Nausea—Paclitaxel—kidney cancer	0.000174	0.00115	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—PTEN—kidney cancer	0.000173	0.00101	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—TP53—kidney cancer	0.000171	0.000997	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PDHB—kidney cancer	0.000171	0.000997	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—CDKN1B—kidney cancer	0.000171	0.000997	CbGpPWpGaD
Gallium nitrate—Pruritus—Capecitabine—kidney cancer	0.00017	0.00113	CcSEcCtD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	0.00017	0.000991	CbGpPWpGaD
Gallium nitrate—Leukopenia—Doxorubicin—kidney cancer	0.00017	0.00113	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—BRAF—kidney cancer	0.000168	0.000983	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000168	0.000979	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—IL2—kidney cancer	0.000167	0.000976	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—MAPK3—kidney cancer	0.000167	0.000974	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000166	0.000972	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Capecitabine—kidney cancer	0.000164	0.00109	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—PSMD7—kidney cancer	0.000164	0.000958	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—CCND1—kidney cancer	0.000163	0.000951	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—RELA—kidney cancer	0.000163	0.00095	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—IFNA1—kidney cancer	0.000163	0.00095	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CASP2—kidney cancer	0.000161	0.000942	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—AKAP13—kidney cancer	0.000161	0.000942	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CCBL1—kidney cancer	0.000161	0.000938	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—MAPK1—kidney cancer	0.000159	0.000927	CbGpPWpGaD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	0.000156	0.000912	CbGpPWpGaD
Gallium nitrate—Confusional state—Doxorubicin—kidney cancer	0.000156	0.00104	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—PSMD7—kidney cancer	0.000155	0.000903	CbGpPWpGaD
Gallium nitrate—Vomiting—Capecitabine—kidney cancer	0.000153	0.00101	CcSEcCtD
Gallium nitrate—TF—Hemostasis—IFNA2—kidney cancer	0.000151	0.000884	CbGpPWpGaD
Gallium nitrate—Rash—Capecitabine—kidney cancer	0.000151	0.00101	CcSEcCtD
Gallium nitrate—Dermatitis—Capecitabine—kidney cancer	0.000151	0.001	CcSEcCtD
Gallium nitrate—Tachycardia—Doxorubicin—kidney cancer	0.000151	0.001	CcSEcCtD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—MAPK3—kidney cancer	0.000151	0.000882	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—AURKA—kidney cancer	0.000151	0.000879	CbGpPWpGaD
Gallium nitrate—TF—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000151	0.000879	CbGpPWpGaD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—CCND1—kidney cancer	0.000149	0.00087	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—SLC2A1—kidney cancer	0.000148	0.000866	CbGpPWpGaD
Gallium nitrate—IL1B—Alzheimers Disease—TP53—kidney cancer	0.000148	0.000864	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—GRB7—kidney cancer	0.000148	0.000861	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—JUNB—kidney cancer	0.000147	0.00086	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CD274—kidney cancer	0.000147	0.000856	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000147	0.000856	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—RAF1—kidney cancer	0.000146	0.00085	CbGpPWpGaD
Gallium nitrate—TF—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000145	0.000849	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—MAPK3—kidney cancer	0.000144	0.000842	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—MAPK1—kidney cancer	0.000144	0.000839	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—JUN—kidney cancer	0.000143	0.000833	CbGpPWpGaD
Gallium nitrate—Nausea—Capecitabine—kidney cancer	0.000143	0.000947	CcSEcCtD
Gallium nitrate—RRM2—G1/S Transition—MYC—kidney cancer	0.000142	0.000828	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—RAF1—kidney cancer	0.000141	0.00082	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—MAPK1—kidney cancer	0.00014	0.00082	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—VHL—kidney cancer	0.00014	0.000816	CbGpPWpGaD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	0.000139	0.000814	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PPAT—kidney cancer	0.000139	0.000813	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GLIPR1—kidney cancer	0.000139	0.000813	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Doxorubicin—kidney cancer	0.000139	0.000923	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle—PSMD7—kidney cancer	0.000138	0.000808	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Doxorubicin—kidney cancer	0.000138	0.000917	CcSEcCtD
Gallium nitrate—IL1B—Signaling by Interleukins—MAPK1—kidney cancer	0.000137	0.000801	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—ITPR2—kidney cancer	0.000137	0.000801	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—IGF2—kidney cancer	0.000136	0.000796	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—AURKA—kidney cancer	0.000135	0.000786	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—MAPK3—kidney cancer	0.000134	0.000785	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—TXNIP—kidney cancer	0.000134	0.000783	CbGpPWpGaD
Gallium nitrate—Constipation—Doxorubicin—kidney cancer	0.000132	0.000879	CcSEcCtD
Gallium nitrate—IL1B—Myometrial Relaxation and Contraction Pathways—JUN—kidney cancer	0.000131	0.000763	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—MYC—kidney cancer	0.000131	0.000763	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—IL2—kidney cancer	0.000131	0.000762	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—JUN—kidney cancer	0.00013	0.000759	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—KRAS—kidney cancer	0.00013	0.000757	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—APRT—kidney cancer	0.000129	0.000756	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—FH—kidney cancer	0.000129	0.000756	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000129	0.000754	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—MAPK1—kidney cancer	0.000128	0.000746	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Doxorubicin—kidney cancer	0.000128	0.000847	CcSEcCtD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—PIK3CA—kidney cancer	0.000125	0.000728	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CTNNA1—kidney cancer	0.000124	0.000726	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—EIF4EBP1—kidney cancer	0.000124	0.000722	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—HSPB1—kidney cancer	0.000124	0.000722	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—TCEB1—kidney cancer	0.000123	0.000716	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—TCEB2—kidney cancer	0.000123	0.000716	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—JUN—kidney cancer	0.000123	0.000716	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Doxorubicin—kidney cancer	0.000122	0.000813	CcSEcCtD
Gallium nitrate—RRM2—Metabolism—GPC3—kidney cancer	0.000122	0.000711	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—CDKN2B—kidney cancer	0.00012	0.0007	CbGpPWpGaD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—MYC—kidney cancer	0.00012	0.000698	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—PIK3CA—kidney cancer	0.000119	0.000695	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000119	0.000692	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CA2—kidney cancer	0.000118	0.000691	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—MAPK3—kidney cancer	0.000118	0.000688	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—TP53—kidney cancer	0.000118	0.000688	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—KEAP1—kidney cancer	0.000117	0.000684	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—ALAD—kidney cancer	0.000115	0.000674	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—TSC1—kidney cancer	0.000115	0.000671	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—ANXA1—kidney cancer	0.000115	0.000671	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PSMD7—kidney cancer	0.000115	0.000671	CbGpPWpGaD
Gallium nitrate—TF—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000115	0.00067	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Doxorubicin—kidney cancer	0.000114	0.000758	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000114	0.000663	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CDKN2B—kidney cancer	0.000113	0.00066	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—ST3GAL2—kidney cancer	0.000113	0.000658	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—MAPK1—kidney cancer	0.000112	0.000655	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—FLT1—kidney cancer	0.000111	0.00065	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	0.000111	0.000647	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—ALDH1A1—kidney cancer	0.00011	0.000643	CbGpPWpGaD
Gallium nitrate—Pruritus—Doxorubicin—kidney cancer	0.000109	0.000727	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—TP53—kidney cancer	0.000107	0.000627	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CASP2—kidney cancer	0.000106	0.000619	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Doxorubicin—kidney cancer	0.000106	0.000703	CcSEcCtD
Gallium nitrate—RRM2—Metabolism—PGK1—kidney cancer	0.000106	0.000616	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—SLC5A3—kidney cancer	0.000106	0.000616	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	0.000105	0.000612	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—LDHB—kidney cancer	0.000104	0.000604	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—JUNB—kidney cancer	0.000103	0.000602	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PAK1—kidney cancer	0.000103	0.000602	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—BRCA2—kidney cancer	0.000102	0.000596	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CD34—kidney cancer	0.000102	0.000593	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—MAPK3—kidney cancer	0.000101	0.000591	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CDKN2B—kidney cancer	0.000101	0.00059	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	9.98e-05	0.000583	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—MYC—kidney cancer	9.85e-05	0.000575	CbGpPWpGaD
Gallium nitrate—Vomiting—Doxorubicin—kidney cancer	9.84e-05	0.000654	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—BIRC5—kidney cancer	9.76e-05	0.00057	CbGpPWpGaD
Gallium nitrate—Rash—Doxorubicin—kidney cancer	9.76e-05	0.000648	CcSEcCtD
Gallium nitrate—Dermatitis—Doxorubicin—kidney cancer	9.75e-05	0.000648	CcSEcCtD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—PIK3CA—kidney cancer	9.73e-05	0.000568	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CARD11—kidney cancer	9.69e-05	0.000566	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—MAPK1—kidney cancer	9.64e-05	0.000563	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—HIF1A—kidney cancer	9.59e-05	0.00056	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—TSC2—kidney cancer	9.56e-05	0.000558	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—RAF1—kidney cancer	9.34e-05	0.000545	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—RELA—kidney cancer	9.3e-05	0.000543	CbGpPWpGaD
Gallium nitrate—Nausea—Doxorubicin—kidney cancer	9.19e-05	0.000611	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—KRAS—kidney cancer	9.1e-05	0.000531	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—ITPR2—kidney cancer	9.01e-05	0.000526	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CA9—kidney cancer	8.97e-05	0.000524	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—BIRC5—kidney cancer	8.73e-05	0.000509	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	8.66e-05	0.000506	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—KIT—kidney cancer	8.45e-05	0.000493	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—APC—kidney cancer	8.45e-05	0.000493	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—IGF2—kidney cancer	8.43e-05	0.000492	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CDKN2B—kidney cancer	8.4e-05	0.00049	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IL2—kidney cancer	8.37e-05	0.000489	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—IGF1R—kidney cancer	8.16e-05	0.000476	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—TP53—kidney cancer	8.09e-05	0.000472	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—BRAF—kidney cancer	7.94e-05	0.000463	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CTSB—kidney cancer	7.82e-05	0.000456	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CTSD—kidney cancer	7.78e-05	0.000454	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CRABP1—kidney cancer	7.63e-05	0.000445	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—PSMD7—kidney cancer	7.55e-05	0.000441	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—RAF1—kidney cancer	7.5e-05	0.000438	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—ITPR2—kidney cancer	7.09e-05	0.000414	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—PAK1—kidney cancer	6.78e-05	0.000396	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—MAPK3—kidney cancer	6.73e-05	0.000393	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—IL2—kidney cancer	6.73e-05	0.000393	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—HIF1A—kidney cancer	6.71e-05	0.000392	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—TSC2—kidney cancer	6.7e-05	0.000391	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—RAF1—kidney cancer	6.63e-05	0.000387	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IFNA1—kidney cancer	6.61e-05	0.000386	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—ERBB2—kidney cancer	6.56e-05	0.000383	CbGpPWpGaD
Gallium nitrate—TF—Transmembrane transport of small molecules—RAF1—kidney cancer	6.49e-05	0.000379	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—MTOR—kidney cancer	6.47e-05	0.000378	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GSTT1—kidney cancer	6.47e-05	0.000378	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—ACHE—kidney cancer	6.47e-05	0.000378	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CDKN2A—kidney cancer	6.47e-05	0.000378	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—CD4—kidney cancer	6.46e-05	0.000377	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—KDR—kidney cancer	6.42e-05	0.000375	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—PTGS2—kidney cancer	6.41e-05	0.000374	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—MAPK1—kidney cancer	6.41e-05	0.000374	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—EGR1—kidney cancer	6.34e-05	0.00037	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IFNA2—kidney cancer	6.16e-05	0.000359	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—SCARB1—kidney cancer	6.12e-05	0.000358	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—CDKN1B—kidney cancer	6.07e-05	0.000355	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PTGS1—kidney cancer	6.06e-05	0.000354	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—KRAS—kidney cancer	6.05e-05	0.000353	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PSMD7—kidney cancer	5.95e-05	0.000347	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—APC—kidney cancer	5.91e-05	0.000345	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—KIT—kidney cancer	5.91e-05	0.000345	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CDKN2A—kidney cancer	5.78e-05	0.000338	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—CTNNB1—kidney cancer	5.74e-05	0.000335	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CDKN1B—kidney cancer	5.73e-05	0.000334	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—VEGFA—kidney cancer	5.72e-05	0.000334	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—BCHE—kidney cancer	5.64e-05	0.000329	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—POMC—kidney cancer	5.63e-05	0.000329	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—PTEN—kidney cancer	5.59e-05	0.000326	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—SLC5A5—kidney cancer	5.57e-05	0.000325	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—BRAF—kidney cancer	5.56e-05	0.000325	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—PIK3CA—kidney cancer	5.56e-05	0.000324	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CCND1—kidney cancer	5.46e-05	0.000319	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—MAPK3—kidney cancer	5.41e-05	0.000316	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—SLC2A1—kidney cancer	5.38e-05	0.000314	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CD8A—kidney cancer	5.18e-05	0.000302	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—MAPK1—kidney cancer	5.15e-05	0.0003	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CDKN1B—kidney cancer	5.12e-05	0.000299	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CCND1—kidney cancer	4.89e-05	0.000285	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—KRAS—kidney cancer	4.86e-05	0.000284	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—MAPK3—kidney cancer	4.78e-05	0.000279	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—MYC—kidney cancer	4.65e-05	0.000271	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—RAF1—kidney cancer	4.64e-05	0.000271	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—RELA—kidney cancer	4.62e-05	0.00027	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—ERBB2—kidney cancer	4.59e-05	0.000268	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—MAPK1—kidney cancer	4.55e-05	0.000265	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—MTOR—kidney cancer	4.53e-05	0.000265	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—MAPK3—kidney cancer	4.51e-05	0.000263	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GSTP1—kidney cancer	4.48e-05	0.000262	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—PIK3CA—kidney cancer	4.47e-05	0.000261	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—TSC2—kidney cancer	4.4e-05	0.000257	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—MYC—kidney cancer	4.38e-05	0.000256	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—TP53—kidney cancer	4.32e-05	0.000252	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—KRAS—kidney cancer	4.29e-05	0.000251	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—MAPK1—kidney cancer	4.29e-05	0.00025	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CDKN1B—kidney cancer	4.25e-05	0.000248	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—ABCB1—kidney cancer	4.24e-05	0.000248	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—IL2—kidney cancer	4.16e-05	0.000243	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GSTM1—kidney cancer	4.12e-05	0.000241	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CCND1—kidney cancer	4.06e-05	0.000237	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—JUN—kidney cancer	4.05e-05	0.000236	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—MAPK3—kidney cancer	4.03e-05	0.000235	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CTNNB1—kidney cancer	4.02e-05	0.000235	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—PIK3CA—kidney cancer	3.95e-05	0.00023	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—MYC—kidney cancer	3.92e-05	0.000229	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PTEN—kidney cancer	3.92e-05	0.000229	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CYP1A1—kidney cancer	3.91e-05	0.000228	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—KIT—kidney cancer	3.89e-05	0.000227	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—MAPK1—kidney cancer	3.83e-05	0.000224	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CDH1—kidney cancer	3.58e-05	0.000209	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—VEGFA—kidney cancer	3.54e-05	0.000206	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—MAPK3—kidney cancer	3.35e-05	0.000195	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—MYC—kidney cancer	3.25e-05	0.00019	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—TP53—kidney cancer	3.22e-05	0.000188	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—MAPK1—kidney cancer	3.18e-05	0.000186	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—RAF1—kidney cancer	3.05e-05	0.000178	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—RELA—kidney cancer	3.04e-05	0.000177	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—ERBB2—kidney cancer	3.02e-05	0.000176	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—KRAS—kidney cancer	3.01e-05	0.000176	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—MTOR—kidney cancer	2.98e-05	0.000174	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CD4—kidney cancer	2.97e-05	0.000174	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—POMC—kidney cancer	2.91e-05	0.00017	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CDKN1B—kidney cancer	2.79e-05	0.000163	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PIK3CA—kidney cancer	2.76e-05	0.000161	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IL2—kidney cancer	2.73e-05	0.00016	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—TP53—kidney cancer	2.67e-05	0.000156	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—JUN—kidney cancer	2.66e-05	0.000155	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CTNNB1—kidney cancer	2.64e-05	0.000154	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—PTEN—kidney cancer	2.57e-05	0.00015	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PTGS2—kidney cancer	2.32e-05	0.000136	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—MAPK3—kidney cancer	2.2e-05	0.000128	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—MAPK1—kidney cancer	2.09e-05	0.000122	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PTEN—kidney cancer	2.03e-05	0.000118	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—KRAS—kidney cancer	1.98e-05	0.000115	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—PIK3CA—kidney cancer	1.82e-05	0.000106	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PIK3CA—kidney cancer	1.43e-05	8.34e-05	CbGpPWpGaD
